Text and Data Mining valid from 2018-04-27
Received: 5 December 2017
Accepted: 6 April 2018
First Online: 27 April 2018
Ethics approval and consent to participate
: Not applicable.
: PG has received consultancy and/or lecture fees from Bayer, Biotest, CSL Behring, NovoNordisk, Pfizer and Shire within the last year. CH has received consultancy and/or lecture fees from Bayer, CSL Behring, NovoNordisk, Pfizer, Shire, SOBI, LFB, OctaPharma within the last year. MB is currently a member of the Roche/Chugai Haemophilia A Advisory Board and is in receipt of funding from Pfizer for an investigator-initiated research study. JB has received speaker’s fees and/or served as a consultant for NovoNordisk, Shire, Octapharma, Pfizer and Roche within last year. CH, BO’M, PdK, AB and KJ state that they have no competing interests to report.